Electra Therapeutics (ETRA) priced its upsized initial public offering of 23.3 million shares at $15 apiece for gross proceeds of about $350 million, the company said Thursday.
The underwriters were granted a 30-day option to purchase up to an additional 3.5 million shares at the public offering price, the company said.
The shares are expected to begin trading on Nasdaq on Friday under the ticker ETRA, with the offering expected to close Monday.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.